General Counsel of $ESPR sells 6,267 shares in insider sale

Benjamin Looker, the General Counsel of $ESPR, recently sold 6,267 shares of the company for approximately $17,572. This sale, which occurred on 09-17-2025, accounted for about 1.6% of their total shares of this class of stock, reducing their ownership to 393,670 shares of $ESPR stock.

In the past six months, $ESPR insiders have engaged in ten trading activities on the stock market. None of these trades involved purchases, with all ten being sales. Among these insider transactions, SHELDON L. KOENIG, the President and CEO, completed two sales of 58,901 shares, fetching an estimated $113,050. Additionally, BENJAMIN HALLADAY, the Chief Financial Officer, executed four sales of 14,294 shares, totaling approximately $28,132. BENJAMIN LOOKER, the General Counsel, sold 13,993 shares across three transactions, amounting to around $26,440. Furthermore, ERIC WARREN, the Chief Commercial Officer, sold 108 shares for approximately $105.

Tracking insider transactions like these can provide valuable insights into a company’s operations and potential performance. For a comprehensive overview of insider trading, individuals can refer to Quiver Quantitative’s insider trading dashboard.

Regarding institutional investment in $ESPR, 67 institutional investors added shares to their portfolios, while 102 reduced their positions in the most recent quarter. Notable movements in institutional holdings include BELLEVUE GROUP AG removing 9,694,064 shares (100.0%) from their portfolio, valued at an estimated $9,542,836. In contrast, PENDERFUND CAPITAL MANAGEMENT LTD. added 4,676,519 shares (233.8%) to their holdings, totaling around $4,603,565. MARSHALL WACE, LLP also added 1,679,294 shares (46.2%) to their portfolio, amounting to an estimated $1,653,097.

Analysts have been closely observing $ESPR, with two firms issuing buy ratings on the stock in recent months. HC Wainwright & Co. and Needham both issued “Buy” ratings on 06/17/2025 and 05/07/2025, respectively. Monitoring analyst ratings and price targets for $ESPR can offer valuable insights into market sentiment and potential future performance. Individuals interested in tracking these ratings can explore Quiver Quantitative’s $ESPR forecast page.

Several analysts have also provided price targets for $ESPR in the last six months, with a median target of $4.0. Notable price targets include Joseph Pantginis from HC Wainwright & Co. setting a target price of $16.0 on 06/17/2025, Serge Belanger from Needham setting a target price of $4.0 on 05/07/2025, and Paul Choi from Goldman Sachs setting a target price of $3.0 on 04/17/2025.

It is essential to note that this article does not constitute financial advice. For further information, individuals are encouraged to review Quiver Quantitative’s disclaimers.